700021P-1MG Display Image

27-HYDROXYCHOLESTEROL

Code: 700021P-1MG D2-231

Application

27-hydroxycholesterol has been used: to test its inhibitory effect on hepatic lipid accumulationas liver X receptor (LXR) ligand in breast cancer cell linesas a c...


read more

Your Price
€108.70 1MG

Application

27-hydroxycholesterol has been used: to test its inhibitory effect on hepatic lipid accumulationas liver X receptor (LXR) ligand in breast cancer cell linesas a control in liquid chromatography with tandem mass spectrometry (LC-MS-MS) for the quantitation of 25-OHC in jejunum samples

Biochem/physiol Actions

27-hydroxycholesterol (27-HC) is a weak liver X receptor (LXR) agonist and a selective estrogen receptor modulator (SERM). Elevated levels of 27-HC is observed in hypercholesterolemia. 27-HC is implicated in breast cancer tumor and glioblastoma progression. 27-HC may help in treating non-alcoholic steatohepatitis. Elevated levels of 27-HC is associated with atherosclerotic lesions.

General description

27-hydroxycholesterol (27-HC) is synthesized from cholesterol by the action of sterol 27-hydroxylase in liver. It is an abundant oxysterol in the circulation ranging from 0.15 to 0.73 μM. 27-HC serves as a substrate for bile synthesis.

Packaging

5 mL Amber Glass Screw Cap Vial (700021P-25mg)

5 mL Amber Glass Screw Cap Vial (700021P-5mg)

5 mL Amber Glass Screw Cap Vial (700021P-1mg)

assay>99% (TLC)
formpowder
InChI keyFYHRJWMENCALJY-YSQMORBQSA-N
InChI1S/C27H46O2/c1-18(17-28)6-5-7-19(2)23-10-11-24-22-9-8-20-16-21(29)12-14-26(20,3)25(22)13-15-27(23,24)4/h8,18-19,21-25,28-29H,5-7,9-17H2,1-4H3/t18-,19-,21+,22+,23-,24+,25+,26+,27-/m1/s1
manufacturer/tradenameAvanti Polar Lipids 700021P
packagingpkg of 1 × 5 mg (700021P-5mg), pkg of 1 × 25 mg (700021P-25mg), pkg of 1 × 1 mg (700021P-1mg)
shipped indry ice
storage temp.−20°C
Code
Description
Unit Size
List Price
Qty
700021P-5MG
Unit:5MG
List Price: €408.91
Source:List Price
ADD
Cas Number20380-11-4
This product has met the following criteria: